Both Th1 and Th17 Abeta-reactive Teffs were found to worsen AD pathology by suppressing anti-inflammatory and immunosuppressive Tregs in both the peripheral nervous system and CNS [132]. This evidence concerns the gene APP and Alzheimer disease.